Log in  First Connection?

Pediatric TransplantArchives

Implementation of a light therapy team to administer photobiomodulation therapy: A standardized protocol to prevent and treat oral mucositis in the pediatric hematopoietic stem cell transplant population

 Published on 02/07/2025 |  Original article (Full-text)  | Kathleen Magee et al. | Pediatric Blood & Cancer 2024; 71(6): 30966

Oral mucositis (OM) is a side effect seen in the majority of pediatric hematopoietic stem cell transplant (HSCT) patients after conditioning chemotherapy. OM has been described as one of the most debilitating side effects of an HSCT, and can cause edema, erythema, and painful ulcers on the oral mucosa,...

Long‐term outcomes for pediatric heart transplant recipients transitioning to adult care teams

 Published on 25/06/2025 |  Original article (Full-text)  | Elena M. Donald et al. | Clinical Transplantation 2024; 38(4): 15282

Long‐term survival rates for pediatric heart transplant (HT) recipients continue to improve, increasing the number that will transition care to an adult specialist. The transition from pediatric to adult care occurs during a vulnerable time of emerging adulthood (between 18 and 25 years of age)...

Identification of Irpex and Rhodotorula on surveillance bronchoscopy in a pediatric lung transplant recipient: A case report and review of literature of these atypical fungal organisms

 Published on 18/06/2025 |  Original article (Full-text)  | Daniel T. Atwood et al. | Pediatric Transplantation 2024; 28(3): 14759

Lung transplantation is a treatment option for pediatric patients with end‐stage pulmonary disease and pulmonary vascular disease, including cystic fibrosis (CF), interstitial lung disease, and pulmonary hypertension. After transplantation, patients require lifelong immunosuppression to reduce...

Optimizing the approach to monitoring allograft inflammation using serial urinary CXCL10/creatinine testing in pediatric kidney transplant recipients

 Published on 11/06/2025 |  Original article (Full-text)  | Ella Barrett‐Chan et al. | Pediatric Transplantation 2024; 28(3): 14718

Acute rejection is associated with premature graft failure and impaired quality of life for pediatric kidney transplant recipients. Early acute cellular rejection is directly associated with later development of donor‐specific antibodies and chronic inflammation in areas of interstitial fibrosis...